Archive for the ‘Food Safety News’ category

FDA warns US Stem Cell Clinic of significant deviations

August 28, 2017

The U.S. Food and Drug Administration today posted a warning letter issued to US Stem Cell Clinic of Sunrise, Florida, and its Chief Scientific Officer Kristin Comella for marketing stem cell products without FDA approval and for significant deviations from current good manufacturing practice requirements, including some that could impact the sterility of their products, […]

FDA acts to remove unproven, potentially harmful treatment used in ‘stem cell’ centers targeting vulnerable patients

August 28, 2017

The U.S. Food and Drug Administration took decisive action to prevent the use of a potentially dangerous and unproven treatment belonging to StemImmune Inc. in San Diego, California, and administered to patients at the California Stem Cell Treatment Centers in Rancho Mirage and Beverly Hills, California. On behalf of the FDA, on Friday, Aug. 25, […]

Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s role in ensuring Americans have access to clear and consistent calorie and nutrition information; forthcoming guidance will provide greater clarity and certainty

August 25, 2017

As a doctor, father and the head of the U.S. Food & Drug Administration, I believe that everyone is entitled to the information they need to make informed decisions about the food they eat. We serve as the nation’s expert on food labeling, which is why Congress entrusted us with the responsibility of crafting predictable, […]

Statement from FDA Commissioner Scott Gottlieb, M.D. – FDA is carefully evaluating prescription opioid medications approved to treat cough in children

August 21, 2017

There’s perhaps no more important mandate that we have at the FDA than safeguarding the health and safety of children. For that reason, I believe it’s important that parents and health care providers have the best information available to inform the decisions they make about a child’s health. There are few more common decisions that […]

FDA provides new tools for the development and proper evaluation of tests for detecting Zika virus infection

August 17, 2017

As an additional measure in the fight against Zika virus, today the U.S. Food and Drug Administration announced that it has made available a panel of human plasma samples to aid in the regulatory evaluation of serological tests to detect recent Zika virus infection.

FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia

August 17, 2017

The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Seven Sundays LLC. Recalls Vanilla Cherry Pecan Muesli Because of Possible Health Risk

August 16, 2017

Seven Sundays LLC of Minneapolis, MN is recalling their Vanilla Cherry Pecan Muesli 12 oz. pouches because it may contain undeclared almonds. People who have an allergy or severe sensitivity to almonds run the risk of serious or life-threatening allergic reaction if they consume these products. Read The Complete Story!

Litehouse Inc. Issues Allergy Alert on Undeclared Egg In Product

August 14, 2017

Litehouse Inc. is voluntarily recalling a limited quantity of its OPA by Litehouse Ranch because it may contain undeclared eggs. The Food and Drug Administration has been made aware of this recall which is limited to one production day from a single manufacturing location. Read The Complete Story!

FDA warns of potential contamination in multiple brands of drugs, dietary supplements

August 11, 2017

The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due to potential contamination with the bacteria Burkholderia cepacia (B. cepacia) and the risk for […]

FDA to expand public education campaign to focus on prevention of youth e-cigarette use

August 8, 2017

Today, the U.S. Food and Drug Administration announced it would pursue a strategic, new public health education campaign aimed at discouraging the use of e-cigarettes and other electronic nicotine delivery systems (ENDS) by kids. The agency plans to expand its “The Real Cost” public education campaign to include messaging to teens about the dangers of […]

Freshtex Produce Recalls “Valery” Brand Maradol Papayas Due to Possible Health Risk

August 7, 2017

Freshtex Produce of Alamo, TX is voluntarily recalling “Valery” brand Maradol Papayas grown and packed by Carica de Campeche, because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected […]

Federal judge enters consent decree against outsourcing facility Isomeric Pharmacy Solutions

August 4, 2017

U.S. District Judge Robert J. Shelby entered a consent decree of permanent injunction yesterday between the United States and Isomeric Pharmacy Solutions of Salt Lake City, Utah, two of the company’s co-owners, William O. Richardson and Rachael S. Cruz, and chief operating officer Jeffery D. Brown.

FDA approves Mavyret for Hepatitis C

August 3, 2017

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis. Mavyret is also approved for adult patients with HCV genotype […]

FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia

August 3, 2017

The U.S. Food and Drug Administration today approved Vyxeos for the treatment of adults with two types of acute myeloid leukemia (AML): newly diagnosed therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of chemotherapy drugs daunorubicin and cytarabine.

Fairway ‘‘Like No Other Market’’ ® Recalls Fairway Brand Cookies Blondie Because Of Possible Health Risk

August 2, 2017

Fairway ‘‘Like No Other Market’’® of New York, NY is voluntarily recalling Fairway brand Cookies Blondie, because the product may contain undeclared ingredient, walnuts. People who have an allergy or severe sensitivity to nuts run the risk of serious or life-threatening allergic reaction if they consume this product. Read The Complete Story!

FDA approves treatment for chronic graft versus host disease

August 2, 2017

The U.S. Food and Drug Administration today expanded the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) after failure of one or more treatments. This is the first FDA-approved therapy for the treatment of cGVHD.

FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia

August 1, 2017

The U.S. Food and Drug Administration today approved Idhifa (enasidenib) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation. The drug is approved for use with a companion diagnostic, the RealTime IDH2 Assay, which is used to detect specific mutations in the IDH2 gene […]

FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death

July 28, 2017

The U.S. Food and Drug Administration today announced a new comprehensive plan for tobacco and nicotine regulation that will serve as a multi-year roadmap to better protect kids and significantly reduce tobacco-related disease and death. The approach places nicotine, and the issue of addiction, at the center of the agency’s tobacco regulation efforts. The goal […]

FDA clears first neonatal magnetic resonance imaging device

July 20, 2017

Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU).

Home | Copyright 2008-2024 FoodandDrugRecall.org